Benzodiazepine and beta-adrenergic receptor ligands independently stimulate phospholipid methylation.
D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology*; D001254:Astrocytoma; D001569:Benzodiazepines; D002460:Cell Line; D008563:Membrane Lipids / Q000378:metabolism; D008745:Methylation; D008780:Methyltransferases / Q000378:metabolism; D010713:Phosphatidylcholines / Q000096:biosynthesis; D010743:Phospholipids / Q000378:metabolism*; D011941:Receptors, Adrenergic / Q000187:drug effects*; D011943:Receptors, Adrenergic, beta / Q000187:drug effects*; D017981:Receptors, Neurotransmitter / Q000187:drug effects*
D000318:Adrenergic beta-Agonists; D014151:Anti-Anxiety Agents; D008563:Membrane Lipids; D010713:Phosphatidylcholines; D010743:Phospholipids; D011941:Receptors, Adrenergic; D011943:Receptors, Adrenergic, beta; D017981:Receptors, Neurotransmitter; D001569:Benzodiazepines; D008780:Methyltransferases